EG ·
vilgat 50MG 30tab
vilgat 50MG 30tab
Composition
These source-reported data require scientific review and are not treatment advice.
VILDAGLIPTIN
· AMOUNT_PER_UNIT
Registration
Packages and prices
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| VILGAT 50MG 10/TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form, route | — EGP |
| DIBAVALLY 50 MG 28 TAB | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| Icandra 50 mg 30 tabs | SAME_ACTIVE_INGREDIENT_SET | dosage_form, route | — EGP |
| sugarlo plus 50 mg 30 tablets | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis, dosage_form | — EGP |
| VILDAGLUSE 50 MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| GLIPTUS PLUS 50/1000 MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| GALVUS MET 50 MG /1000 MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | — EGP |
| VILGAT 50 MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| GLIPTUS PLUS 50/850MG 30TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| SUGARLO PLUS 50/850 MG 30/TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| ICANDRA PLUS 1000MG 10/TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| GLIPTUS 50 MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |